<DOC>
	<DOCNO>NCT02289196</DOCNO>
	<brief_summary>Patients histologically proven malignancy document disease control ( objective response stable disease ) Not Evaluable Disease ( NED ) expectancy &gt; 6 month ; HLA-A*02 positive patient . The primary objective trial compare safety tolerability four different dos Vx-006 . The secondary objective compare immunogenicity four different dos Vx-006 .</brief_summary>
	<brief_title>Safety Study Vx006 Vaccine Solid Tumor Patients</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female &gt; = 18 year age ; 2 . Histologically proven malignancy ; 3 . Documented HLAA*02 positivity , determined central laboratory ; 4 . Disease control ( Complete Response ( CR ) , Partial Response ( PR ) , Stable Disease ( SD ) ) accord Response Evaluation Criteria In Solid Tumors ( RECIST 1.1 ) criterion NED case patient receive adjuvant chemotherapy 5 . Patient disease control NED expectancy &gt; = 6 month accord investigator opinion ; 6 . ECOG performance status 0 , 1 ; 7 . Patients must adequate renal hepatic function assess standard laboratory criterion ; 8 . Patients must adequate haematological function : Platelet count &gt; = 100 x 109/L ; White Blood Cell ( WBC ) count &gt; = 2.5 x 109/L ; Haemoglobin &gt; = 90g /L ; 9 . Female patient must nonchildbearing potential ( i.e. , woman function ovary document tubal ligation hysterectomy , ovariectomy woman postmenopausal ) . Women childbearing potential must negative urine pregnancy test baseline agree practice adequate contraception 30 day prior administration investigational product , throughout study treatment period 30 day completion injection ; 10 . In investigator 's opinion , patient capable willing comply requirement study ; 11 . Willing able sign write informed consent . 1 . Prior treatment cancer vaccine ; 2 . Treatment immunotherapy ( e.g. , interferon , interleukin , Tumor Necrosis Factor ( TNF ) , biological response modifier , GranulocyteMacrophage Colony Stimulating Factor ( GMCSF ) etc ) within four week prior first vaccination ; 3 . Treatment immunosuppressive agent ( include corticosteroid ) within 2 week prior first vaccination ; 4 . Treatment investigational drug , within 4 week prior first vaccination ; 5 . Autoimmune immunodeficiency disease opinion investigator may compromise safety patient study ; 6 . Any preexist medical condition require concomitant systemic corticosteroid immunosuppressive therapy . The use inhale corticosteroid Chronic Obstructive Pulmonary Disease ( COPD ) topical steroid allow ; 7 . Known hepatitis B and/or C infection document patient file , test require ; 8 . Known HIVpositivity , test require ; 9 . Clinically significant hepatic dysfunction ( Alanine amino transferase ( ALT ) &gt; 2.5 time normal upper limit [ ULN ] , Aspartate Amino Transferase ( AST ) &gt; 2.5 time Upper Limit Normal ( ULN ) , bilirubin &gt; 1.5 time ULN ) ; 10 . Clinically significant renal dysfunction ( serum creatinine &gt; 1.5 time ULN ) ; 11 . Uncontrolled congestive heart failure hypertension , unstable heart disease ( coronary artery disease unstable angina myocardial infarction within 6 month enrolment ) uncontrolled ventricular arrhythmias time enrolment study ( atrial fibrillation flutter acceptable ) ; 12 . Splenectomy splenic irradiation ; 13 . Any infectious condition , opinion investigator , could compromise patient 's ability develop immune response ; 14 . Pregnant lactating female ( female patient childbearing potential undertake pregnancy test screen study completion/withdrawal visit ) ; 15 . Alcohol drug dependence ; 16 . Requirement concurrent treatment prohibit medication ( investigational product , anticancer treatment include chemotherapy , nonpalliative radiotherapy , biological agent immunomodulating agent , systemic immunosuppressive agent , include systemic corticosteroid ) ; 17 . The investigator consider patient unfit study result medical interview , physical examination , screen investigation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Vaccine</keyword>
</DOC>